222 related articles for article (PubMed ID: 16899793)
1. Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification.
Getty-Kaushik L; Song DH; Boylan MO; Corkey BE; Wolfe MM
Obesity (Silver Spring); 2006 Jul; 14(7):1124-31. PubMed ID: 16899793
[TBL] [Abstract][Full Text] [Related]
2. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
Thondam SK; Daousi C; Wilding JP; Holst JJ; Ameen GI; Yang C; Whitmore C; Mora S; Cuthbertson DJ
Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E224-E233. PubMed ID: 28073779
[TBL] [Abstract][Full Text] [Related]
3. Glucose-dependent insulin modulation of oscillatory lipolysis in perifused rat adipocytes.
Getty-Kaushik L; Richard AM; Corkey BE
Obes Res; 2005 Dec; 13(12):2058-65. PubMed ID: 16421338
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes.
Timper K; Grisouard J; Sauter NS; Herzog-Radimerski T; Dembinski K; Peterli R; Frey DM; Zulewski H; Keller U; Müller B; Christ-Crain M
Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E1-13. PubMed ID: 23092914
[TBL] [Abstract][Full Text] [Related]
5. Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes.
Hauner H; Glatting G; Kaminska D; Pfeiffer EF
Ann Nutr Metab; 1988; 32(5-6):282-8. PubMed ID: 3076052
[TBL] [Abstract][Full Text] [Related]
6. Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin.
McIntosh CH; Bremsak I; Lynn FC; Gill R; Hinke SA; Gelling R; Nian C; McKnight G; Jaspers S; Pederson RA
Endocrinology; 1999 Jan; 140(1):398-404. PubMed ID: 9886851
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes.
Zhang T; He J; Xu C; Zu L; Jiang H; Pu S; Guo X; Xu G
J Mol Endocrinol; 2009 Jan; 42(1):57-66. PubMed ID: 18955435
[TBL] [Abstract][Full Text] [Related]
8. Individual and combined effects of GIP and xenin on differentiation, glucose uptake and lipolysis in 3T3-L1 adipocytes.
English A; Craig SL; Flatt PR; Irwin N
Biol Chem; 2020 Oct; 401(11):1293-1303. PubMed ID: 32769216
[TBL] [Abstract][Full Text] [Related]
9. GIP biology and fat metabolism.
Yip RG; Wolfe MM
Life Sci; 2000; 66(2):91-103. PubMed ID: 10666005
[TBL] [Abstract][Full Text] [Related]
10. Curcumin attenuates lipolysis stimulated by tumor necrosis factor-α or isoproterenol in 3T3-L1 adipocytes.
Xie XY; Kong PR; Wu JF; Li Y; Li YX
Phytomedicine; 2012 Dec; 20(1):3-8. PubMed ID: 23083815
[TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids.
Gögebakan Ö; Andres J; Biedasek K; Mai K; Kühnen P; Krude H; Isken F; Rudovich N; Osterhoff MA; Kintscher U; Nauck M; Pfeiffer AF; Spranger J
Diabetes; 2012 Feb; 61(2):292-300. PubMed ID: 22179810
[TBL] [Abstract][Full Text] [Related]
12. [The mechanisms of stimulated lipolysis by high concentration of glucose in primary rat adipocytes].
Zhang TT; Xu C; Zu LX; He JH; Pu SS; Guo XH; Xu GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 40(3):273-9. PubMed ID: 18560455
[TBL] [Abstract][Full Text] [Related]
13. Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide.
Khan R; Tomas A; Rutter GA
Peptides; 2020 Mar; 125():170201. PubMed ID: 31751656
[TBL] [Abstract][Full Text] [Related]
14. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
[TBL] [Abstract][Full Text] [Related]
15. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol.
Ren T; He J; Jiang H; Zu L; Pu S; Guo X; Xu G
J Mol Endocrinol; 2006 Aug; 37(1):175-83. PubMed ID: 16901933
[TBL] [Abstract][Full Text] [Related]
17. Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes.
Nie Y; Ma RC; Chan JC; Xu H; Xu G
FASEB J; 2012 Jun; 26(6):2383-93. PubMed ID: 22366643
[TBL] [Abstract][Full Text] [Related]
18. Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes.
Irwin N; Gault VA; O'Harte FPM; Flatt PR
Peptides; 2020 Mar; 125():170203. PubMed ID: 31733230
[TBL] [Abstract][Full Text] [Related]
19. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
Thondam SK; Cuthbertson DJ; Wilding JPH
Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
[TBL] [Abstract][Full Text] [Related]
20. Recent advances of GIP and future horizons.
Holst JJ; Rosenkilde MM
Peptides; 2020 Mar; 125():170230. PubMed ID: 31838219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
